Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer combination win
admin 18th October 2018 Uncategorised 0Merck’s Keytruda knows how to make an entrance. On Thursday, it hit the scene with kidney cancer combination data that could snag it a new indication months earlier than anticipated.
More: Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer combination win
Source: fierce